Hear+Now – What Retinal Patients Report Beyond Visual Acuity

A patient with wet AMD can read the eye chart just fine and still struggle to navigate everyday life once they leave the clinic. Standard visual acuity testing often misses the functional and psychological realities that matter most to patients — from night driving to symptoms they're too hesitant to mention on their own. This audio digest explores what a clinic visit typically overlooks, and two direct questions that can help close that gap. Listen in to learn more.

This audio digest was generated with the assistance of an AI tool and reviewed by a member of our Editorial Team and Health Union Medical Review Board. This information is provided for general knowledge and is not a substitute for professional medical advice.

Transcript:

Speaker 1: Today we're talking about retinal disease and what patients report beyond visual acuity. So providers imagine a patient reads the eye chart just fine in a brightly lit clinic, right?

Speaker 2: Yeah, they leave feeling confident.

Speaker 1: But an hour later, that same patient is white-knuckling the steering wheel on a dark road, just completely terrified.

Speaker 2: It is a stark contrast. Looking at the 2026 In America survey, it shows standard clinical assessments are just missing the functional metrics that actually dictate patients' lives.

Speaker 1: Night driving is the highest rated functional impact, right?

Speaker 2: Exactly. For providers managing wet AMD, in particular, the data points squarely at functional impacts. You know, when ranking negative impacts on daily activities, night driving sits at the absolute top.

Speaker 1: Rating far above reading. And this is plainly not what clinic assessment centers on, you know. Because standard assessments center on the static clinic eye chart, which is, you know, brightly lit and high contrast. But patients deal with a dynamic, unpredictable reality, like navigating a dark road. It raises the question if standard assessments are completely missing the functional metrics that actually dictate a patient's life.

Speaker 2: Well, the open-ended survey answers really back that up.

Speaker 1: The responses are overwhelmingly about autonomy, right? Not visual acuity.

Speaker 2: Yeah, exactly, autonomy. It is about a sudden inability to rely on oneself. One patient wrote that being unable to drive has taken away a great amount of independence.

Speaker 1: And another specifically cited the logistical toll, mentioning a 100-mile round trip to the retina specialist.

Speaker 2: Right, requiring a four to five-hour drive just to get treatment.

Speaker 1: Vision loss rapidly translates to a loss of mobility. And that transition from the physical loss of autonomy leads to an underreported psychological burden, specifically visual hallucinations.

Speaker 2: Yes, Charles Bonnet Syndrome, which is common in central vision loss. The data shows, however, that about half of these patients were never told the condition exists.

Speaker 2: And 40% told no one about the symptoms. It's important to note there is zero difference in psychiatric comorbidity among those who experience it versus those who don't.

Speaker 1: But if there is no psychiatric difference and patients actively hide the symptom, how can providers be expected to uncover a symptom patients deliberately conceal?

Speaker 2: Well, providers must ask about it directly. Patients fear the stigma, so they won't volunteer the information. Naming the symptom normalizes it, you know? By explaining that many people with similar eye conditions see things that aren't there, providers hold the key to treating the anxiety simply by bringing it up.

Speaker 1: And shifting the narrative to diabetes, that is another major elicitation problem.

Speaker 2: Oh, absolutely. Blurred vision is common, yet almost nobody raises vision issues when asked about diabetes generally.

Speaker 1: Because of the systemic nature, patients compartmentalize the symptoms, right?

Speaker 2: Right. So asking a diabetic patient generally how they feel misses the vision aspect almost entirely.

Speaker 1: Which means screening should be scheduled, not symptom-triggered.

Speaker 2: Precisely. Waiting for a report of a vision issue is waiting too long. The clear referral threshold is moderate or worse non-proliferative retinopathy. And you have to remember, most of these patients see primary care, not endocrinology. So the safety net relies entirely on scheduled screening.

Speaker 1: Looking at the typical patient in this data, they are mostly in their late 70s, retired, and already under the care of a retina specialist. So they are already in the clinic.

Speaker 2: Exactly. The core theme across all these findings is that the true burden sits exactly where the visit does not ask.

Speaker 1: Which means providers can take two specific actions. First, ask about night driving.

Speaker 2: Yes. And second, ask about hallucinations.

Speaker 1: Those two questions can bridge the gap between clinical measurement and lived experiences. And here is a final thought to ponder. Since the heaviest burdens are functional and psychological, could the future of retinal care mean integrating occupational therapy directly into the clinical workflow?